Alzheimer’s disease is devastating to families and many of those patients also suffer from heart problems. Pioneering MUSC research show the same toxic proteins cause both, with potential for therapy.

Experts believe the retina may predict Alzheimer's risk because it is part of the central nervous system and connected ...

Scientists are working hard to find better ways to treat Alzheimer’s disease, one of the most common causes of memory loss and dementia around the world. A new study from researchers at the University ...

It was just last year that the FDA cleared a new blood test for Alzheimer's disease.

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...

Alzheimer’s disease is the most common cause of dementia in older adults. It slowly damages the brain and leads to memory loss, confusion, and difficulty thinking. Over time, people with Alzheimer’s ...

Researchers identified a blood immune signature linked to amyloid-related imaging abnormalities in patients receiving Alzheimer’s antibody therapy. The findings may help predict treatment side effects ...

Researchers found that tau proteins don’t jump straight into forming Alzheimer’s-associated fibrils—first they assemble into soft, reversible clusters. When the clusters were dissolved, fibril growth ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Scientists discovered that lowering a specific molecule helps microglia switch into a protective state that quiets brain inflammation in Alzheimer’s. A small group of these cells seems to have an ...

BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the ...

Former Eisai and Eli Lilly Alzheimer’s disease leader joins executive team to advance commercialization strategy for ...